NADAV MOR

Allopathic & Osteopathic Physicians|Emergency Medicine AUSTIN, TX NPI 1043440639

General Payments — all program years on this page

$25,648.47

  • Category: General Payments
  • Program years: PY2019–2022
  • Record count: 43
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $6,964.07 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

By paying entity

Latest program year (PY2022) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $6,964.0714

By program year

Program yearAmountRecords
2019 $7,750.1312
2020 $1,550.002
2021 $9,384.2715
2022 $6,964.0714

Records — PY2022 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
914622815 AstraZeneca Pharmaceuticals LP $254.98 09/15/2022 Travel and Lodging Undisputed 01/23/2026 View at CMS
914679397 AstraZeneca Pharmaceuticals LP $254.98 09/15/2022 Travel and Lodging Undisputed 01/23/2026 View at CMS
914686231 AstraZeneca Pharmaceuticals LP $18.04 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
914839129 AstraZeneca Pharmaceuticals LP $250.05 09/15/2022 Travel and Lodging Undisputed 01/23/2026 View at CMS
914911315 AstraZeneca Pharmaceuticals LP $254.98 09/15/2022 Travel and Lodging Undisputed 01/23/2026 View at CMS
914991371 AstraZeneca Pharmaceuticals LP $1,685.00 02/17/2022 Consulting Fee Undisputed 01/23/2026 View at CMS
915019623 AstraZeneca Pharmaceuticals LP $250.00 04/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
915024117 AstraZeneca Pharmaceuticals LP $21.93 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
915135489 AstraZeneca Pharmaceuticals LP $60.14 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
915192631 AstraZeneca Pharmaceuticals LP $42.10 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
915440483 AstraZeneca Pharmaceuticals LP $3,250.00 11/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
915612913 AstraZeneca Pharmaceuticals LP $557.84 09/15/2022 Travel and Lodging Undisputed 01/23/2026 View at CMS
915635359 AstraZeneca Pharmaceuticals LP $21.93 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
915793035 AstraZeneca Pharmaceuticals LP $42.10 09/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.